David‐Neto 2014.

Trial name or title	A randomized, prospective study comparing everolimus/low tacrolimus with regular tacrolimus/MPS for the elderly renal transplant recipients
Methods	Parallel RCT
Participants	Elderly patients referred for kidney transplantation; 1 month post‐transplant
Interventions	Treatment group Low TAC trough levels: 2 to 4 ng/mL EVL trough levels: 3 to 8 ng/mL Control group Regular TAC trough levels: 5 to12 ng/mL MPS Both groups Steroids ATG induction therapy: single dose 2 mg/kg
Outcomes	AR DM Infection BK virus CMV infection
Starting date	36 patients have been evaluated of the total 90 planned
Contact information	David‐Neto, E
Notes